US Appeals Court Upholds Delay in Alzheimer's Drug Swap

May 22, 2015 5:56 PM

14 0

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

New York Attorney General Eric Schneiderman had sought the order and called the Court of Appeals ruling a victory for consumers.

Also read: EU Court Adviser Backs Intel Appeal Over $1.17 Billion Fine

Read more

To category page